mhurhangee/patent-ind-claim-en huggingface dataset:
A method for attaching at least one application to a coating , such as a film coating, having telescopic folding, wherein the method comprises the following method steps: a) Pushing of one or more folds (L1, L2, L3) of a first layer of the coating onto a first folding aid ; b) Fixing of the fold(s) of the first layer (L1, L2) preferably using a second folding aid ; c) Unfolding of the coating up to the fixed fold(s) (L1, L2); d) Attachment of the at least one application onto or into the unfolded layer (L3, L4) of the coating ; e) Folding back of the unfolded layer(s) (L3, L4) by folding in the first layer against an edge of the first folding aid to form a further fold; f) Opening of the fixing and removal of the folds (L1, L2, L3, L4) from the first folding aid ; g) Pushing of the folds (L1, L2, L3, L4) onto the first folding aid and fixing of the folds; h) Repetition of method steps e) to g) until the coating is folded back. a) Pushing of one or more folds (L1, L2, L3) of a first layer of the coating onto a first folding aid ; b) Fixing of the fold(s) of the first layer (L1, L2) preferably using a second folding aid ; c) Unfolding of the coating up to the fixed fold(s) (L1, L2); d) Attachment of the at least one application onto or into the unfolded layer (L3, L4) of the coating ; e) Folding back of the unfolded layer(s) (L3, L4) by folding in the first layer against an edge of the first folding aid to form a further fold; f) Opening of the fixing and removal of the folds (L1, L2, L3, L4) from the first folding aid ; g) Pushing of the folds (L1, L2, L3, L4) onto the first folding aid and fixing of the folds; h) Repetition of method steps e) to g) until the coating is folded back.
Method of removing lipopolysaccharide from an aqueous medium comprising gelatin and lipopolysaccharides, said method comprising the steps of: 1) providing an aqueous medium comprising at least 2 w/w% gelatin and lipopolysaccharides, 2) adding to the aqueous medium 0.01 - 1.5 w/w% of a micelle-forming surfactant, 3) contacting the medium of step 2) with a solid adsorbent, 4) separating the solid adsorbent of step 3) from the medium, 5) recovering the aqueous medium comprising the gelatin, wherein each of the steps 1) - 5) are performed at a temperature of 68 °C or less, said temperature being below the cloud point of the micelle-forming surfactant, at least steps 2) and 3) being performed at a temperature of at least 30 °C. 1) providing an aqueous medium comprising at least 2 w/w% gelatin and lipopolysaccharides, 2) adding to the aqueous medium 0.01 - 1.5 w/w% of a micelle-forming surfactant, 3) contacting the medium of step 2) with a solid adsorbent, 4) separating the solid adsorbent of step 3) from the medium, 5) recovering the aqueous medium comprising the gelatin, wherein each of the steps 1) - 5) are performed at a temperature of 68 °C or less, said temperature being below the cloud point of the micelle-forming surfactant, at least steps 2) and 3) being performed at a temperature of at least 30 °C.
A silicon negative electrode sheet , comprising: a current collector ; and at least two active coating layers containing negative active materials, sequentially coated on the current collector , the negative active materials containing silicon materials; being characterized in that through holes are formed in each of the active coating layers , the through holes extending vertically through the respective active coating layer and wherein the through holes are arranged at intervals in the active coating layers ; and among the at least two active coating layers , a silicon content of an active coating layer proximal to the current collector is higher than a silicon content of an active coating layer distal from the current collector . a current collector ; and at least two active coating layers containing negative active materials, sequentially coated on the current collector , the negative active materials containing silicon materials; being characterized in that through holes are formed in each of the active coating layers , the through holes extending vertically through the respective active coating layer and wherein the through holes are arranged at intervals in the active coating layers ; and among the at least two active coating layers , a silicon content of an active coating layer proximal to the current collector is higher than a silicon content of an active coating layer distal from the current collector .
An aerosol-delivery component comprising: a tank for containing a liquid aerosol precursor; a vaporising chamber housing a vaporiser ; a wall separating the vaporising chamber from the tank ; and a vent channel having a longitudinal axis , the vent channel extending through the wall from a first opening at the vaporising chamber to a second opening at the tank ; characterised in that the longitudinal axis of the vent channel is configured to intersect the vaporiser such that leakage of aerosol precursor through the channel is discharged onto the vaporiser . a tank for containing a liquid aerosol precursor; a vaporising chamber housing a vaporiser ; a wall separating the vaporising chamber from the tank ; and a vent channel having a longitudinal axis , the vent channel extending through the wall from a first opening at the vaporising chamber to a second opening at the tank ; characterised in that the longitudinal axis of the vent channel is configured to intersect the vaporiser such that leakage of aerosol precursor through the channel is discharged onto the vaporiser .
A substrate processing apparatus , comprising: a sealed pressure vessel forming an outer chamber that surrounds an inner chamber which is a sealed reaction chamber ; a fluid inlet assembly attached to a wall of the sealed pressure vessel , the fluid inlet assembly having a fluid inlet pipe configured to provide the inner chamber with chemicals, wherein the fluid inlet pipe passes through the wall of the sealed pressure vessel and has a contact point with a wall of the inner chamber , the apparatus further comprising: a resilient element in the fluid inlet assembly around the fluid inlet pipe coupling the inlet pipe to the wall of the sealed pressure vessel , where one of an interior surface and an exterior surface of the resilient element sees pressure prevailing within the pressure vessel and the other sees ambient pressure, and where the fluid inlet pipe prevents fluid carried inside from being in contact with the resilient element . a sealed pressure vessel forming an outer chamber that surrounds an inner chamber which is a sealed reaction chamber ; a fluid inlet assembly attached to a wall of the sealed pressure vessel , the fluid inlet assembly having a fluid inlet pipe configured to provide the inner chamber with chemicals, wherein the fluid inlet pipe passes through the wall of the sealed pressure vessel and has a contact point with a wall of the inner chamber , the apparatus further comprising: a resilient element in the fluid inlet assembly around the fluid inlet pipe coupling the inlet pipe to the wall of the sealed pressure vessel , where one of an interior surface and an exterior surface of the resilient element sees pressure prevailing within the pressure vessel and the other sees ambient pressure, and where the fluid inlet pipe prevents fluid carried inside from being in contact with the resilient element .
A method of monitoring, or obtaining an indication of, the length of an electrode of an arc smelting system , wherein the method includes: measuring the current in/running through the electrode during operation; determining, by using a processor, the variation of the measured current over a period of time; deriving, by using a processor, a current variation value which is indicative of the electrode length, wherein the derivation of the current variation value is based on at least the determined variation of current over the period of time. measuring the current in/running through the electrode during operation; determining, by using a processor, the variation of the measured current over a period of time; deriving, by using a processor, a current variation value which is indicative of the electrode length, wherein the derivation of the current variation value is based on at least the determined variation of current over the period of time.
A system for engineering a tissue comprising: at least one cassette having a flexible sheet covering at least one pumping chamber, the flexible sheet covering at least one cassette fluid valve; a bioreactor housing the tissue, the bioreactor being in fluid communication with the at least one cassette; a controller generating at least one controller command; and at least one valve module, each of the at least one valve modules, having at least one pressure bus, each of the at least one valve modules having at least one valve operably communicating with the pressure bus, each of the at least one valve modules having an outlet port, the outlet port being associated with each of the at least one valves, the outlet port operably communicating with the flexible sheet, the at least one valve module including a first module having a first module processor, the first module processor receiving the at least one controller command, the first module processor generating, based on the controller command, at least one second module command addressed to at least one second module, the at least one second module having a second module processor receiving the at least one second module command and generating, based on the at least second module command, at least one valve command governing fluid flow through the at least one valve of the at least one second module, the at least one valve controlling pressure applied to the flexible sheet via the outlet ports, the at least one controller command metering the fluid flow to the tissue and the bioreactor, the tissue being decellularized based on the fluid flow. at least one cassette having a flexible sheet covering at least one pumping chamber, the flexible sheet covering at least one cassette fluid valve; a bioreactor housing the tissue, the bioreactor being in fluid communication with the at least one cassette; a controller generating at least one controller command; and at least one valve module, each of the at least one valve modules, having at least one pressure bus, each of the at least one valve modules having at least one valve operably communicating with the pressure bus, each of the at least one valve modules having an outlet port, the outlet port being associated with each of the at least one valves, the outlet port operably communicating with the flexible sheet, the at least one valve module including a first module having a first module processor, the first module processor receiving the at least one controller command, the first module processor generating, based on the controller command, at least one second module command addressed to at least one second module, the at least one second module having a second module processor receiving the at least one second module command and generating, based on the at least second module command, at least one valve command governing fluid flow through the at least one valve of the at least one second module, the at least one valve controlling pressure applied to the flexible sheet via the outlet ports, the at least one controller command metering the fluid flow to the tissue and the bioreactor, the tissue being decellularized based on the fluid flow.
A method of producing a nanoemulsion comprising nano droplets comprising alkyd, said nano droplets are dispersed in an aqueous liquid, the method comprising the step of: a) providing an alkyd mixture comprising an alkyd and a source of unsaturated hydroxy fatty acid (suhfa), said source comprises: i) a free, unsaturated hydroxy fatty acid (fuhfa), ii) an oligoester of unsaturated hydroxy fatty acid (ouhfa), and/or iii) a hydroxy carboxylic acid ester of i) or ii) (hcuhfa) wherein the hydroxy carboxylic acid has a molecular weight of at most 250 g/mol, b) optionally, adding an alkalizing agent to deprotonate at least some of carboxylic acids of the alkyd mixture, c) forming a nanoemulsion of the alkyd mixture in an aqueous liquid. a) providing an alkyd mixture comprising an alkyd and a source of unsaturated hydroxy fatty acid (suhfa), said source comprises: i) a free, unsaturated hydroxy fatty acid (fuhfa), ii) an oligoester of unsaturated hydroxy fatty acid (ouhfa), and/or iii) a hydroxy carboxylic acid ester of i) or ii) (hcuhfa) wherein the hydroxy carboxylic acid has a molecular weight of at most 250 g/mol, i) a free, unsaturated hydroxy fatty acid (fuhfa), ii) an oligoester of unsaturated hydroxy fatty acid (ouhfa), and/or iii) a hydroxy carboxylic acid ester of i) or ii) (hcuhfa) wherein the hydroxy carboxylic acid has a molecular weight of at most 250 g/mol, b) optionally, adding an alkalizing agent to deprotonate at least some of carboxylic acids of the alkyd mixture, c) forming a nanoemulsion of the alkyd mixture in an aqueous liquid.
A method for manufacturing at least one cutting edge structure from a polymeric material, the cutting edge structure being a razor blade or a portion of a razor blade box , the method comprising the steps of: (a) providing a computer model of a cutting edge structure ; (b) providing a precursor material ; (c) activating portions of said precursor material in a focal point of electromagnetic radiation while at least one substrate is disposed in said precursor material, wherein a wavelength of said radiation is about double a wavelength required to activate said precursor material , and wherein the substrate comprises a blade body or blade support for said at least one cutting edge structure; (d) moving the focal point of said radiation within said precursor material to form at least one cutting edge structure on said substrate based on said model; and (e) curing portions of said activated precursor material to produce said cutting edge structure comprised of a polymeric material, wherein a series of closely spaced narrow cutting edge elements adjacent to each other are produced, and the cutting edge elements are joined to form an extended cutting edge structure with an extended cutting edge . (a) providing a computer model of a cutting edge structure ; (b) providing a precursor material ; (c) activating portions of said precursor material in a focal point of electromagnetic radiation while at least one substrate is disposed in said precursor material, wherein a wavelength of said radiation is about double a wavelength required to activate said precursor material , and wherein the substrate comprises a blade body or blade support for said at least one cutting edge structure; (d) moving the focal point of said radiation within said precursor material to form at least one cutting edge structure on said substrate based on said model; and (e) curing portions of said activated precursor material to produce said cutting edge structure comprised of a polymeric material, wherein a series of closely spaced narrow cutting edge elements adjacent to each other are produced, and the cutting edge elements are joined to form an extended cutting edge structure with an extended cutting edge .
A method of operating a user equipment, UE, that is configured to operate in accordance with different wireless personal area network, WPAN, radio access technologies, RATs, characterised in that each of the different WPAN RATs is associated with a different communication protocol, the method comprising: prioritizing a plurality of WPAN RATs supported by the UE; and dynamically allocating a plurality of shared WPAN radios to the plurality of WPAN RATs based on the prioritizing, wherein each of the plurality of shared WPAN radios is dynamically configurable to support communications over each of the plurality of WPAN RATs in accordance with the dynamic allocating. prioritizing a plurality of WPAN RATs supported by the UE; and dynamically allocating a plurality of shared WPAN radios to the plurality of WPAN RATs based on the prioritizing, wherein each of the plurality of shared WPAN radios is dynamically configurable to support communications over each of the plurality of WPAN RATs in accordance with the dynamic allocating.
A space wind farm, consisting of a plurality of tower structures which carry a plurality of wind generators (G) arranged one above the other and which are laterally braced by tendons which run laterally away from the tower structure , characterized in that the tendons extending between the tower structures are each held on the ground side in the tower foot region (F) of the neighboring tower structure.
A method for performing color measurement using a standard light source color matching observation box, wherein a halogen tungsten lamp and a light filter are arranged in the color matching observation box for cooperation, the light ray of the halogen tungsten lamp emits a main body radiation light ray through the light filter; a plurality of narrow-wave LED light sources of different light-emitting wavelengths are arranged to emit a compensation light ray; the main body radiation light ray and the compensation light ray are mixed in the color matching observation box into a mixed light ray that uniformly simulates a standard D illuminant; and the mixed light ray serves as a light source to perform a color measurement on a measured object in the color matching observation box; characterised in that when the halogen tungsten lamp and the narrow-wave LED light sources are in operation, the halogen tungsten lamp is an illumination main body which provides main illumination energy, and the illumination energy of the narrow-wave LED light sources occupy 20% or less of the total radiation energy.
Method of isolating a target region of a nucleic acid molecule, said method comprising the steps of: a. contacting a population of nucleic acid molecules with at least one Type II Cas protein-gRNA complex, wherein said gRNA comprises a guide segment that is complementary to a sequence comprised in the target region of at least one nucleic acid molecule, thereby forming a Type II Cas protein-gRNA-nucleic acid complex, b. optionally, contacting the population of nucleic acid molecules with at least one protector molecule, c. contacting the population of nucleic acid molecules with at least one enzyme having exonuclease activity, and optionally at least one site-specific endonuclease, thus degrading nucleic acid molecules that are not comprised in said Type II Cas protein-gRNA-nucleic acid complex, and d. isolating said target region from the Type II Cas protein-gRNA-nucleic acid complex formed in step a), comprising the addition of EDTA and/or at least one protease. a. contacting a population of nucleic acid molecules with at least one Type II Cas protein-gRNA complex, wherein said gRNA comprises a guide segment that is complementary to a sequence comprised in the target region of at least one nucleic acid molecule, thereby forming a Type II Cas protein-gRNA-nucleic acid complex, b. optionally, contacting the population of nucleic acid molecules with at least one protector molecule, c. contacting the population of nucleic acid molecules with at least one enzyme having exonuclease activity, and optionally at least one site-specific endonuclease, thus degrading nucleic acid molecules that are not comprised in said Type II Cas protein-gRNA-nucleic acid complex, and d. isolating said target region from the Type II Cas protein-gRNA-nucleic acid complex formed in step a), comprising the addition of EDTA and/or at least one protease.
A bispecific antibody compound comprising two first polypeptide chains and two second polypeptide chains wherein each of, a.) said first polypeptide chain comprises a single chain variable fragment (scFv) and a mAb IgG heavy chain (HC), the HC having a heavy chain variable region (HCVR1) comprising heavy chain CDRs (HCDR) 1-3 wherein the amino acid sequence of HCDR1 is SEQ ID NO:9, the amino acid sequence of HCDR2 is SEQ ID NO:10, the amino acid sequence of HCDR3 is SEQ ID NO:11, and the scFv having a heavy chain variable region (HCVR2) and a light chain variable region (LCVR2), HCVR2 comprising HCDRs 4-6 and LCVR2 comprising LCDRs 4-6, wherein the amino acid sequence of HCDR4 is SEQ ID NO:12, the amino acid sequence of HCDR5 is SEQ ID NO:13, the amino acid sequence of HCDR6 is SEQ ID NO:14, the amino acid sequence of LCDR4 is SEQ ID NO:18, the amino acid sequence of LCDR5 is SEQ ID NO:19, and the amino acid sequence of LCDR6 is SEQ ID NO:20; and b.) said second polypeptide comprises a mAb light chain (LC) comprising light chain CDRs (LCDR) 1-3, wherein the amino acid sequence of LCDR1 is SEQ ID NO:15, the amino acid sequence of LCDR2 is SEQ ID NO:16, the amino acid sequence of LCDR3 is SEQ ID NO:17, wherein each scFv is independently linked to said HC via polypeptide linker (L1) covalently attached to the N-terminus of HC and the C-terminus of LCVR2, and LCVR2 is linked to HCVR2 of the same scFv via a second polypeptide linker (L2) covalently attached to the C-terminus of LCVR2 and the N-terminus of HCVR2. a.) said first polypeptide chain comprises a single chain variable fragment (scFv) and a mAb IgG heavy chain (HC), the HC having a heavy chain variable region (HCVR1) comprising heavy chain CDRs (HCDR) 1-3 wherein the amino acid sequence of HCDR1 is SEQ ID NO:9, the amino acid sequence of HCDR2 is SEQ ID NO:10, the amino acid sequence of HCDR3 is SEQ ID NO:11, and the scFv having a heavy chain variable region (HCVR2) and a light chain variable region (LCVR2), HCVR2 comprising HCDRs 4-6 and LCVR2 comprising LCDRs 4-6, wherein the amino acid sequence of HCDR4 is SEQ ID NO:12, the amino acid sequence of HCDR5 is SEQ ID NO:13, the amino acid sequence of HCDR6 is SEQ ID NO:14, the amino acid sequence of LCDR4 is SEQ ID NO:18, the amino acid sequence of LCDR5 is SEQ ID NO:19, and the amino acid sequence of LCDR6 is SEQ ID NO:20; and b.) said second polypeptide comprises a mAb light chain (LC) comprising light chain CDRs (LCDR) 1-3, wherein the amino acid sequence of LCDR1 is SEQ ID NO:15, the amino acid sequence of LCDR2 is SEQ ID NO:16, the amino acid sequence of LCDR3 is SEQ ID NO:17,